-Ikuo Saiki Researcher Activity Profile

Research Author Detailed Information 

Ikuo Saiki Publication Rate By Year

Ikuo Saiki has published 1 paper(s) in 1982, 1 paper(s) in 1983, 7 paper(s) in 2007, 4 paper(s) in 2008, for a total of 13 research publications in total.

Ikuo I Saiki Author Information

LAST NAME: saiki

FIRST NAME: Ikuo

INITIALS: i

AFFILIATION:

Papers

Ikuo Saiki's Publication Record

1. Novel inhibitor for fibroblast growth factor receptor tyrosine kinase. Year Published: 2007
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand.
2. Identification of a predictive biomarker for the beneficial effect of a Kampo (Japanese traditional) medicine keishibukuryogan in rheumatoid arthritis patients. Year Published: 2007
Central Research Laboratories, Tsumura and Co., Ibaraki, Japan.
3. Chemokine receptors in cancer metastasis and cancer cell-derived chemokines in host immune response. Year Published: 2007
Division of Pathogenic Biochemistry, Institute of Natural Medicine, University of Toyama, Toyama 930-0194, Japan. kkoizumi@inm.u-toyama.ac.jp
4. RANKL-induced down-regulation of CX3CR1 via PI3K/Akt signaling pathway suppresses Fractalkine/CX3CL1-induced cellular responses in RAW264.7 cells. Year Published: 2007
Division of Pathogenic Biochemistry, Institute of Natural Medicine, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.
5. Structures and biological activities of peptidoglycans of Listeria monocytogenes and Propionibacterium acnes. Year Published: 1982
6. Structural and immunochemical studies of teichoic acid of Listeria monocytogenes. Year Published: 1983
7. Identification of a predictive biomarker for the beneficial effect of a Kampo (Japanese traditional) medicine keishibukuryogan in rheumatoid arthritis patients. Year Published: 2007
Central Research Laboratories, Tsumura and Co., Ibaraki, Japan.
8. Chemokine receptors in cancer metastasis and cancer cell-derived chemokines in host immune response. Year Published: 2007
Division of Pathogenic Biochemistry, Institute of Natural Medicine, University of Toyama, Toyama 930-0194, Japan. kkoizumi@inm.u-toyama.ac.jp
9. RANKL-induced down-regulation of CX3CR1 via PI3K/Akt signaling pathway suppresses Fractalkine/CX3CL1-induced cellular responses in RAW264.7 cells. Year Published: 2007
Division of Pathogenic Biochemistry, Institute of Natural Medicine, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.
10. Chemokine receptor CXCR4 expression and prognosis in patients with metastatic prostate cancer. Year Published: 2008
Department of Urology, Graduate School of Medicine and Pharmaceutical Sciences for Research, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan. akashi@med.u-toyama.ac.jp
11. A ginseng saponin metabolite suppresses tumor necrosis factor-alpha-promoted metastasis by suppressing nuclear factor-kappaB signaling in murine colon cancer cells. Year Published: 2008
Division of Pathogenic Biochemistry, Institute of Natural Medicine, University of Toyama, Toyama 930-0194, Japan.
12. A ginseng saponin metabolite suppresses tumor necrosis factor-alpha-promoted metastasis by suppressing nuclear factor-kappaB signaling in murine colon cancer cells. Year Published: 2008
Division of Pathogenic Biochemistry, Institute of Natural Medicine, University of Toyama, Toyama 930-0194, Japan.
13. Differential effect of intestinal neuropeptides on invasion and migration of colon carcinoma cells in vitro. Year Published: 2008
Department of Pathogenic Biochemistry, Research Institute for Wakan-yaku, Toyama Medical and Pharmaceutical University, 2630 Sugitani, Toyama 930-01, Japan.